These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

81 related articles for article (PubMed ID: 9237050)

  • 1. The Neurotoxicity Scale--II. Results of a patient-based scale assessing neurotoxicity in patients with epilepsy.
    Aldenkamp AP; Baker GA
    Epilepsy Res; 1997 Jun; 27(3):165-73. PubMed ID: 9237050
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluating subjective cognitive impairment in the adult epilepsy clinic: Effects of depression, number of antiepileptic medications, and seizure frequency.
    Feldman L; Lapin B; Busch RM; Bautista JF
    Epilepsy Behav; 2018 Apr; 81():18-24. PubMed ID: 29455082
    [TBL] [Abstract][Full Text] [Related]  

  • 3. EpiTrack: tracking cognitive side effects of medication on attention and executive functions in patients with epilepsy.
    Lutz MT; Helmstaedter C
    Epilepsy Behav; 2005 Dec; 7(4):708-14. PubMed ID: 16266826
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Portland Neurotoxicity Scale: validation of a brief self-report measure of antiepileptic-drug-related neurotoxicity.
    Salinsky MC; Storzbach D
    Assessment; 2005 Mar; 12(1):107-17. PubMed ID: 15695749
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The A-B neuropsychological assessment schedule (ABNAS): the further refinement of a patient-based scale of patient-perceived cognitive functioning.
    Brooks J; Baker GA; Aldenkamp AP
    Epilepsy Res; 2001 Mar; 43(3):227-37. PubMed ID: 11248534
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Influence of major antiepileptic drugs on attention, reaction time, and speed of information processing: results from a randomized, double-blind, placebo-controlled withdrawal study of seizure-free epilepsy patients receiving monotherapy.
    Hessen E; Lossius MI; Reinvang I; Gjerstad L
    Epilepsia; 2006 Dec; 47(12):2038-45. PubMed ID: 17201701
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Randomized double-blind parallel-group study comparing cognitive effects of a low-dose lamotrigine with valproate and placebo in healthy volunteers.
    Aldenkamp AP; Arends J; Bootsma HP; Diepman L; Hulsman J; Lambrechts D; Leenen L; Majoie M; Schellekens A; de Vocht J
    Epilepsia; 2002 Jan; 43(1):19-26. PubMed ID: 11879382
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lamotrigine adjunctive therapy among children and adolescents with primary generalized tonic-clonic seizures.
    Trevathan E; Kerls SP; Hammer AE; Vuong A; Messenheimer JA
    Pediatrics; 2006 Aug; 118(2):e371-8. PubMed ID: 16847080
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Epilepsy in patients with primary brain tumors: The impact on mood, cognition, and HRQOL.
    Rahman Z; Wong CH; Dexter M; Olsson G; Wong M; Gebsky V; Nahar N; Wood A; Byth K; King M; Bleasel AB
    Epilepsy Behav; 2015 Jul; 48():88-95. PubMed ID: 26136184
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The cognitive and psychomotor effects of remacemide and carbamazepine in newly diagnosed epilepsy.
    Wesnes KA; Edgar C; Dean AD; Wroe SJ
    Epilepsy Behav; 2009 Mar; 14(3):522-8. PubMed ID: 19111629
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Determining the effects of antiepileptic drugs on cognitive function in pediatric patients with epilepsy.
    Bourgeois BF
    J Child Neurol; 2004 Aug; 19 Suppl 1():S15-24. PubMed ID: 15526967
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cognitive effects of lacosamide as adjunctive therapy in refractory epilepsy.
    IJff DM; van Veenendaal TM; Majoie HJ; de Louw AJ; Jansen JF; Aldenkamp AP
    Acta Neurol Scand; 2015 Jun; 131(6):347-54. PubMed ID: 25630655
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Cognitive effects of antiepileptic drugs].
    Malagón-Valdez J
    Rev Neurol; 2003 Feb 1-15; 36(3):288-92. PubMed ID: 12599162
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of gabapentin and carbamazepine on the EEG and cognition in healthy volunteers.
    Salinsky MC; Binder LM; Oken BS; Storzbach D; Aron CR; Dodrill CB
    Epilepsia; 2002 May; 43(5):482-90. PubMed ID: 12027908
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The development of a seizure severity scale as an outcome measure in epilepsy.
    Baker GA; Smith DF; Dewey M; Morrow J; Crawford PM; Chadwick DW
    Epilepsy Res; 1991 Apr; 8(3):245-51. PubMed ID: 1868824
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Postmarketing experience with topiramate and cognition.
    Tatum WO; French JA; Faught E; Morris GL; Liporace J; Kanner A; Goff SL; Winters L; Fix A;
    Epilepsia; 2001 Sep; 42(9):1134-40. PubMed ID: 11580760
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluating the longer-term cognitive effects of adjunctive perampanel compared to lacosamide in a naturalistic outpatient setting.
    Meschede C; Witt JA; Rademacher M; von Wrede RD; Elger CE; Helmstaedter C
    Seizure; 2018 May; 58():141-146. PubMed ID: 29704679
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Validation of the Chinese version of the Liverpool Adverse Events Profile in patients with epilepsy.
    Chen HF; Tsai YF; Shih MS; Chen JC
    Epilepsy Res; 2011 Mar; 94(1-2):45-52. PubMed ID: 21324650
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The A-B neuropsychological assessment schedule (ABNAS): the relationship between patient-perceived drug related cognitive impairment and results of neuropsychological tests.
    Aldenkamp AP; van Meel HF; Baker GA; Brooks J; Hendriks MP
    Seizure; 2002 Jun; 11(4):231-7. PubMed ID: 12027569
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Translation, cross-cultural adaptation, and validation of the Bulgarian version of the Liverpool Adverse Event Profile.
    Kuzmanova R; Stefanova I; Velcheva I; Stambolieva K
    Epilepsy Behav; 2014 Oct; 39():88-91. PubMed ID: 25238552
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.